Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
195 GBX | +5.41% | +8.33% | -36.07% |
May. 22 | Transcript : Faron Pharmaceuticals Oy - Special Call | |
May. 20 | Faron Pharmaceuticals’ Blood Cancer Combo Shows Efficacy in Mid-stage Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.07% | 169M | |
+14.89% | 118B | |
+13.03% | 106B | |
-3.08% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-16.93% | 15.56B | |
+4.75% | 13.63B | |
+28.72% | 12.27B |
- Stock Market
- Equities
- FARN Stock
- News Faron Pharmaceuticals Oy
- Faron Pharmaceuticals’ Blood Cancer Combo Shows Efficacy in Mid-stage Study